Conditional Survival in Pancreatic Adenocarcinoma Patients Treated with Neoadjuvant FOLFIRINOX and Chemoradiation

被引：0
|
作者：
Sekigami, Yurie [1 ]
Michelakos, Theodoros [1 ]
Kontos, Filippos [1 ]
Qadan, Motaz [1 ]
Catalano, Onofrio Antonio [1 ]
Deshpande, Vikram [1 ]
Lillemoe, Keith D. [1 ]
Ferrone, Cristina Rosa [1 ]
机构：
[1] Massachusetts Gen Hosp, Boston, MA 02114 USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS | 2020年 / 231卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：S155 / S156
页数：2
相关论文
共 50 条
  • [1] Intraoperative Radiation Mitigates the Effect of Microscopically Positive Tumor Margins on Survival Among Pancreatic Adenocarcinoma Patients Treated with Neoadjuvant FOLFIRINOX and Chemoradiation
    Yurie Sekigami
    Theodoros Michelakos
    Carlos Fernandez-del Castillo
    Filippos Kontos
    Motaz Qadan
    Jennifer Y. Wo
    Jon Harrison
    Vikram Deshpande
    Onofrio Catalano
    Keith D. Lillemoe
    Theodore S. Hong
    Cristina R. Ferrone
    [J]. Annals of Surgical Oncology, 2021, 28 : 4592 - 4601
  • [2] Intraoperative Radiation Mitigates the Effect of Microscopically Positive Tumor Margins on Survival Among Pancreatic Adenocarcinoma Patients Treated with Neoadjuvant FOLFIRINOX and Chemoradiation
    Sekigami, Yurie
    Michelakos, Theodoros
    Fernandez-del Castillo, Carlos
    Kontos, Filippos
    Qadan, Motaz
    Wo, Jennifer Y.
    Harrison, Jon
    Deshpande, Vikram
    Catalano, Onofrio
    Lillemoe, Keith D.
    Hong, Theodore S.
    Ferrone, Cristina R.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (08) : 4592 - 4601
  • [3] Intraoperative Radiation Mitigates the Effect of Microscopically Positive Tumor Margins on Survival Among Pancreatic Adenocarcinoma Patients Treated with Neoadjuvant FOLFIRINOX and Chemoradiation
    Sekigami, Y.
    Michelakos, T.
    Kontos, F.
    Fernandez del-Castillo, C.
    Wo, J. Y.
    Harrison, J. M.
    Deshpande, V.
    Qadan, M.
    Lillemoe, K. D.
    Hong, T. S.
    Ferrone, C. R.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (SUPPL 1) : S134 - S134
  • [4] Conditional Survival in Resected Pancreatic Ductal Adenocarcinoma Patients Treated with Total Neoadjuvant Therapy
    Theodoros Michelakos
    Yurie Sekigami
    Filippos Kontos
    Carlos Fernández-del Castillo
    Motaz Qadan
    Vikram Deshpande
    David T. Ting
    Jeffrey W. Clark
    Colin D. Weekes
    Aparna Parikh
    David P. Ryan
    Jennifer Y. Wo
    Theodore S. Hong
    Jill N. Allen
    Onofrio Catalano
    Andrew L. Warshaw
    Keith D. Lillemoe
    Cristina R. Ferrone
    [J]. Journal of Gastrointestinal Surgery, 2021, 25 : 2859 - 2870
  • [5] Conditional Survival in Resected Pancreatic Ductal Adenocarcinoma Patients Treated with Total Neoadjuvant Therapy
    Michelakos, Theodoros
    Sekigami, Yurie
    Kontos, Filippos
    Fernandez-del Castillo, Carlos
    Qadan, Motaz
    Deshpande, Vikram
    Ting, David T.
    Clark, Jeffrey W.
    Weekes, Colin D.
    Parikh, Aparna
    Ryan, David P.
    Wo, Jennifer Y.
    Hong, Theodore S.
    Allen, Jill N.
    Catalano, Onofrio
    Warshaw, Andrew L.
    Lillemoe, Keith D.
    Ferrone, Cristina R.
    [J]. JOURNAL OF GASTROINTESTINAL SURGERY, 2021, 25 (11) : 2859 - 2870
  • [6] Post-therapy pathologic stage and survival in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant chemoradiation
    Estrella, Jeannelyn S.
    Rashid, Asif
    Fleming, Jason B.
    Katz, Matthew H.
    Lee, Jeffrey E.
    Wolf, Robert A.
    Varadhachary, Gauri R.
    Pisters, Peter W. T.
    Abdalla, Eddie K.
    Vauthey, Jean-Nicolas
    Wang, Hua
    Gomez, Henry F.
    Evans, Douglas B.
    Abbruzzese, James L.
    Wang, Huamin
    [J]. CANCER, 2012, 118 (01) : 268 - 277
  • [7] Perioperative and Survival Outcomes Following Neoadjuvant FOLFIRINOX versus Gemcitabine Abraxane in Patients with Pancreatic Adenocarcinoma
    Chapman, Brandon C.
    Gleisner, Ana
    Rigg, Devin
    Messersmith, Wells
    Paniccia, Alessandro
    Meguid, Cheryl
    Gajdos, Csaba
    McCarter, Martin D.
    Schulick, Richard D.
    Edil, Barish H.
    [J]. JOURNAL OF THE PANCREAS, 2018, 19 (02): : 75 - 85
  • [8] Full dose neoadjuvant FOLFIRINOX is associated with prolonged survival in patients with locally advanced pancreatic adenocarcinoma
    Khushman, Moh'd
    Dempsey, Naomi
    Maldonado, Jennifer Cudris
    Loaiza-Bonilla, Arturo
    Velez, Michel
    Carcas, Lauren
    Dammrich, Daniel
    Hurtado-Cordovi, Jorge
    Parajuli, Ritesh
    Pollack, Terri
    Harwood, Ana P.
    Macintyre, Jessica
    Tzeng, Ching-Wei D.
    Merchan, Jaime R.
    Restrepo, Maria H.
    Akunyili, Ikechukwu I.
    Ribeiro, Afonso
    Narayanan, Govindarajan
    Portelance, Lorraine
    Sleeman, Danny
    Levi, Joe U.
    Lima, Caio M. S. Rocha
    Hosein, Peter J.
    [J]. PANCREATOLOGY, 2015, 15 (06) : 667 - 673
  • [9] Treatment response and survival in patients with pancreatic adenocarcinoma receiving neoadjuvant chemotherapy or chemoradiation.
    Khattab, Ahmed
    Patruni, Sunita
    Abel, Stephen
    Hasan, Shaakir
    Finley, Gene Grant
    Monga, Dulabh K.
    Wegner, Rodney E.
    Verma, Vivek
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [10] Dose escalation with a vessel boost in pancreatic adenocarcinoma treated with neoadjuvant chemoradiation
    Wang, Lora S.
    Shaikh, Talha
    Handorf, Elizabeth A.
    Hoffman, John P.
    Cohen, Steven J.
    Meyer, Joshua E.
    [J]. PRACTICAL RADIATION ONCOLOGY, 2015, 5 (05) : E457 - E463
12345